文献速递药物不良反应与药物警戒药物相互作用

托斯卡纳地区医用大麻不良事件:意大利植物警戒数据库分析

Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database.
PubMed 文献 · Br J Clin Pharmacol · 2020-01-03

结论认为大麻总体耐受良好,多数不良事件轻微且短暂,但强调滴定阶段需准确监测处方,尤其合并用药时。

要点

  • 医用大麻相关不良事件以精神和神经系统紊乱最常见。
  • 滴定阶段及合并用药时需加强处方监测。

核心结论

  • 医用大麻总体耐受良好,多数不良事件轻微且短暂。
  • 临床实践中需重视滴定阶段的准确处方监测,尤其存在合并用药时。

研究设计与样本

  • 采用世界卫生组织-乌普萨拉监测中心标准进行因果关系评估。

主要发现

  • 最常报告的系统器官分类为精神和神经系统紊乱。
  • 16例存在潜在药物相互作用。

临床怎么用

  • 医用大麻处方期间应加强监测,尤其滴定阶段和合并用药患者。
  • 关注精神和神经系统不良事件及潜在药物相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Despite a significant increase in using cannabis for medical purposes, current evidence on its safety in real-world clinical practice is still poorly characterised. By a case-by-case analysis of spontaneous reports of suspected adverse events (AEs) collected in Tuscany within the Italian Phytovigilance database, the aim of the present study was to describe AEs occurred in patients exposed to medical cannabis. METHODS: We evaluated all reports of cannabis-related suspected AEs collected within the Phytovigilance database up to December 2018. Information regarding cannabis therapy, patient's demographic and clinical characteristics, concomitant medications, AE description according to the Medical Dictionary for Regulatory Activities (MedDRA) classification, AE seriousness and AE outcome, were collected. The causality assessment was performed following World Health Organisation-Uppsala Monitoring Centre criteria. RESULTS: Fifty-three cannabis-related AE reports were analysed. The majority of patients were females (77.3%), with a mean age of 61.9 years. Thirty-nine (73.6%) cases were defined as nonserious and the majority of them (86.9%) showed a complete resolution or improvement. Forty-six (86.8%) cases were judged as probably related to cannabis consumption. The most frequently reported system organ class was psychiatric and nervous system disorders, and a potential drug-drug interaction was present in 16 cases. CONCLUSION: Cannabis was generally well tolerated and the majority of AEs were mild and transient. Our analysis highlighted important safety issues for clinical practice, in particular the need for an accurate prescription monitoring during the titration phase, particularly in the presence of concomitant medications.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Crescioli G, Lombardi N, Bettiol A, et al. Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database. Br J Clin Pharmacol. 2020. PMID: 31656045. doi:10.1111/bcp.14140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。